Trade AbCellera Biologics Inc. - ABCL stock price

5.33
-0.01%
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. The company also develops next-generation transgenic mice that provide a source of fully-human antibodies for the discovery of therapeutic antibody candidates. It has a discovery partnership agreement with Eli Lilly and Company for the discovery of various targets. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.
White Paper Declaration

ABCL price history

Date Close Change Chg% Open Min. Max.
2022-09-30 5.26 -0.42 -7.39 5.68 5.26 5.68
2022-09-30 5.63 -0.01 -0.18 5.64 5.56 5.79
2022-09-30 5.69 -0.21 -3.56 5.9 5.69 6.01
2022-09-30 5.93 0.16 2.77 5.77 5.5 6.01
2022-09-30 5.76 -0.50 -7.99 6.26 5.75 6.41
2022-09-30 6.43 0.42 6.99 6.01 5.92 6.51
2022-09-30 6.13 -0.42 -6.41 6.55 6.02 6.64
2022-09-30 6.69 -0.18 -2.62 6.87 6.59 6.88
2022-09-30 6.71 0.07 1.05 6.64 6.41 6.84
2022-09-30 6.47 -0.17 -2.56 6.64 6.37 6.72
2022-09-30 6.76 -0.49 -6.76 7.25 6.56 7.25
2022-09-30 7.25 0.27 3.87 6.98 6.77 7.47
2022-09-30 7.08 -0.33 -4.45 7.41 7.01 7.65
2022-09-30 7.66 -0.57 -6.93 8.23 7.43 8.35

Mobile app

Full trading account functionality: order execution and cancellation, stop-loss and take-profit setup, transaction history, deposits and withdrawals

iOS
4,7
12 127 reviews
Android
4,1
9 795 reviews
Go help.dzengi.com
Dzengi Exchange
Trade BTC & tokenized stocks